Patients who had liver fibrosis were more frequently male, were older and had higher BMI, SBP, DBP, FPG, TG, serum uric acid, lower HDL-C and worse liver function including higher ALT than those who did not have NAFLD liver fibrosis (all P < 0.05) (Table 2). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.